FDA approves first human milk-based fortifier for term infants to support growth and recovery following surgery for Gastroschisis
Type: Press Releases
Topic(s): Feeding Intolerance Growth Product
Study shows vat pasteurization outperforms other methods in preserving human milk’s native bioactive properties
Type: Press Releases
Topic(s): Clinical Studies Pasteurization Quality & Safety
Study finds fewer cases of Necrotizing Enterocolitis in premature infants and cost savings after implementing an Exclusive Human Milk Diet
Type: Press Releases
Topic(s): Clinical Studies Necrotizing Entercolitis (NEC)
test page
Type: Parent Stories
Topic(s): Parents
Hot Topics in Neonatology® 2024 Conference to feature symposium on clinical impact & cost savings of an Exclusive Human Milk Diet
Type: Press Releases
Topic(s): Conferences and Events Cost Savings / Cost Effectiveness Feeding Protocols
Meet Shiloh the warrior and his donor mom Kathy
Type: Parent Stories
Topic(s): 22-27 weeks (extremely premature) 26 weeker Parents
Prolacta celebrates advancements in neonatal care during Prematurity Awareness Month
Type: Press Releases
Topic(s): Company
Humavant® 100% human milk-based fortifiers helping premature infants in Australia grow and develop
Type: Press Releases
Topic(s): Company Growth
Prolacta Bioscience appoints Dr. Sandra Sullivan as director of clinical education and professional development
Type: Employee Stories Press Releases
Topic(s): Company
Not finding the reference you’re looking for?
Use our main search field or email us at info@prolacta.com